Dermata Therapeutics Files 8-K
Ticker: DRMAW · Form: 8-K · Filed: May 21, 2025 · CIK: 1853816
| Field | Detail |
|---|---|
| Company | Dermata Therapeutics, Inc. (DRMAW) |
| Form Type | 8-K |
| Filed Date | May 21, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulation-fd, corporate-events
Related Tickers: DRMA
TL;DR
DRMA filed an 8-K, but it's light on details. Need to dig deeper.
AI Summary
Dermata Therapeutics, Inc. filed an 8-K on May 21, 2025, reporting events on May 20, 2025. The filing indicates a Regulation FD Disclosure and other events, but lacks specific details on the nature of these events or any associated financial figures.
Why It Matters
This 8-K filing signals important corporate events at Dermata Therapeutics, Inc., though the specific nature of these events requires further investigation.
Risk Assessment
Risk Level: medium — The filing is an 8-K, which typically reports material events, but the lack of specific details in the provided text makes it difficult to assess the immediate impact or risk.
Key Players & Entities
- Dermata Therapeutics, Inc. (company) — Registrant
- May 20, 2025 (date) — Earliest event reported
- May 21, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- 3525 Del Mar Heights Rd., #322, San Diego, CA 92130 (address) — Principal executive offices
FAQ
What specific event triggered the Regulation FD Disclosure for Dermata Therapeutics?
The provided text of the 8-K filing does not specify the exact event that triggered the Regulation FD Disclosure.
What are the 'Other Events' reported in this 8-K filing?
The filing indicates 'Other Events' were reported, but the specific nature of these events is not detailed in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on May 20, 2025.
What is Dermata Therapeutics, Inc.'s principal executive office address?
Dermata Therapeutics, Inc.'s principal executive office is located at 3525 Del Mar Heights Rd., #322, San Diego, CA 92130.
What is the SEC File Number for Dermata Therapeutics, Inc.?
The SEC File Number for Dermata Therapeutics, Inc. is 001-40739.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 21, 2025 regarding Dermata Therapeutics, Inc. (DRMAW).